Peethaambaran Kunnathoor, Chennai Friday, March 28, 2025, 08:00 Hrs [IST] ...

Telangana: Drugs Control Administration, Telangana, has seized Spurious Drugs (Counterfeit Versions) 'Montek-LC' Tablets ...

On Tuesday, India’s top specialty generics company Sun Pharma announced the acquisition of the US-based Checkpoint for $355 million to enhance its oncology portfolio. Analysts view this ...

Sun Pharma shares rose like the sun in the intraday trade on Tuesday, as the company shares surged by over 2 per cent in the first half of the day's trade. This came to pass after a landmark ...

Often referred to as the "Father of Modern China," Sun held a pivotal role in overthrowing the Qing dynasty and establishing the Republic of China. Sun Yat-sen expressed his support for Zionism in ...

Sun Pharmaceutical Industries Ltd. 524715 shares rallied 2.76% to 1,655.65 Indian rupees Tuesday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX ...

Sun Pharma share price today reached ₹1,651.80, a 2.50% rise from its last close of ₹1,611.50. The rise is despite the overall market downtrend, highlighting Sun Pharma's strength in the pharma ...

Sun Pharmaceutical Industries Ltd led the gainers, rising 2.62 per cent to close at ₹1,653.30. ICICI Bank followed, advancing 2.49 per cent to ₹1,244.80, supported by strong institutional buying.

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

Mahmoud Khalil, a Columbia University student who helped lead last year’s pro-Palestinian demonstrations, was detained by the Department of Homeland Security on Saturday. Photo: Jeenah Moon ...

Sun Pharmaceutical Industries Limited on Monday announced that it will acquire Checkpoint, an immunotherapy and targeted oncology company. According to the company’s exchange filing, Checkpoint ...

Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company. The deal involves an upfront cash payment of $4.10 per share, totaling up ...